[1]
Rosamond W, Flegal K, Furie K, et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics--2008 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008; 117(4): e25-e146.
[2]
Bravata DM, Ho SY, Meehan TP, Brass LM, Concato J. Readmission and death after hospitalization for acute ischemic stroke: 5-year follow-up in the medicare population. Stroke 2007; 38(6): 1899-904.
[3]
Feng W, Hendry RM, Adams RJ. Risk of recurrent stroke, myocardial infarction, or death in hospitalized stroke patients. Neurology 2010; 74(7): 588-93.
[4]
Antithrombotic Trialists’ Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002; 324(7329): 71-86.
[5]
Gouya G, Arrich J, Wolzt M, et al. Antiplatelet treatment for prevention of cerebrovascular events in patients with vascular diseases: A systematic review and meta-analysis. Stroke 2014; 45(2): 492-503.
[6]
Hong KS, Yegiaian S, Lee M, Lee J, Saver JL. Declining stroke and vascular event recurrence rates in secondary prevention trials over the past 50 years and consequences for current trial design. Circulation 2011; 123(19): 2111-9.
[7]
Lee M, Wu YL, Ovbiagele B. Trends in incident and recurrent rates of first-ever ischemic stroke in Taiwan between 2000 and 2011. J Stroke 2016; 18(1): 60-5.
[8]
Bergström L, Irewall AL, Söderström L, Ögren J, Laurell K, Mooe T. One-year incidence, time trends, and predictors of recurrent ischemic stroke in Sweden from 1998 to 2010: An observational study. Stroke 2017; 48(8): 2046-51.
[9]
Lovett JK, Coull AJ, Rothwell PM. Early risk of recurrence by subtype of ischemic stroke in population-based incidence studies. Neurology 2004; 62(4): 569-73.
[10]
Ruland S, Richardson D, Hung E, et al. AAASPS investigators. Predictors of recurrent stroke in African Americans. Neurology 2006; 67(4): 567-71.
[11]
Pennlert J, Eriksson M, Carlberg B, Wiklund PG. Long-term risk and predictors of recurrent stroke beyond the acute phase. Stroke 2014; 45(6): 1839-41.
[12]
Zhang C, Zhao X, Wang C, et al. Chinese Intra Cranial AtheroSclerosis (CICAS) study group. Prediction factors of recurrent ischemic events in one year after minor stroke. PLoS One 2015; 10(3): e0120105.
[13]
Kolominsky-Rabas PL, Sarti C, Heuschmann PU, et al. A prospective community-based study of stroke in Germany--the Erlangen Stroke Project (ESPro): Incidence and case fatality at 1, 3, and 12 months. Stroke 1998; 29(12): 2501-6.
[14]
Lee TH, Chang CH, Chang YJ, Chang KC, Chung J. Chang Gung Medical System Stroke Registry Group. Establishment of electronic chart-based stroke registry system in a medical system in Taiwan. J Formos Med Assoc 2011; 110(8): 543-7.
[15]
Breiman LFJOR, Stone CJ. Classification and regression trees. New York: Chapman & Hall 1984.
[16]
Dhamoon MS, Sciacca RR, Rundek T, Sacco RL, Elkind MS. Recurrent stroke and cardiac risks after first ischemic stroke: The Northern Manhattan Study. Neurology 2006; 66(5): 641-6.
[17]
Mohan KM, Crichton SL, Grieve AP, Rudd AG, Wolfe CD, Heuschmann PU. Frequency and predictors for the risk of stroke recurrence up to 10 years after stroke: The South London Stroke Register. J Neurol Neurosurg Psychiatry 2009; 80(9): 1012-8.
[18]
Kang K, Park TH, Kim N, et al. Recurrent stroke, myocardial infarction, and major vascular events during the first year after acute ischemic stroke: The multicenter prospective observational study about recurrence and its determinants after acute ischemic stroke I. J Stroke Cerebrovasc Dis 2016; 25(3): 656-64.
[19]
Sun Y, Lee SH, Heng BH, Chin VS. 5-year survival and rehospitalization due to stroke recurrence among patients with hemorrhagic or ischemic strokes in Singapore. BMC Neurol 2013; 13: 133.
[20]
Salehi M, Amiri A, Thrift AG, et al. Five-year recurrence rate and the predictors following stroke in the Mashhad stroke incidence study: A population-based cohort study of stroke in the Middle East. Neuroepidemiology 2018; 50(1-2): 18-22.
[21]
Burn J, Dennis M, Bamford J, Sandercock P, Wade D, Warlow C. Long-term risk of recurrent stroke after a first-ever stroke. The Oxfordshire Community Stroke Project. Stroke 1994; 25(2): 333-7.
[22]
Boysen G, Truelsen T. Prevention of recurrent stroke. Neurol Sci 2000; 21(2): 67-72.
[23]
Kauw F, Takx RAP, de Jong HWAM, Velthuis BK, Kappelle LJ, Dankbaar JW. Clinical and imaging predictors of recurrent ischemic stroke: A systematic review and meta-analysis. Cerebrovasc Dis 2018; 45(5-6): 279-87.
[24]
Ay H, Gungor L, Arsava EM, et al. A score to predict early risk of recurrence after ischemic stroke. Neurology 2010; 74(2): 128-35.
[25]
Lemon SC, Roy J, Clark MA, Friedmann PD, Rakowski W. Classification and regression tree analysis in public health: Methodological review and comparison with logistic regression. Ann Behav Med 2003; 26(3): 172-81.
[26]
Pan Y, Chen W, Xu Y, et al. Genetic polymorphisms and clopidogrel efficacy for acute ischemic stroke or transient ischemic attack: A systematic review and meta-analysis. Circulation 2017; 135(1): 21-33.
[27]
Martínez-Martínez M, Cazorla-García R, Rodríguez de Antonio LA, Martínez-Sánchez P, Fuentes B, Diez-Tejedor E. Hypercoagulability and ischemic stroke in young patients. Neurologia 2010; 25(6): 343-8.
[28]
Hart RG, Pearce LA, Bakheet MF, et al. Predictors of stroke recurrence in patients with recent lacunar stroke and response to interventions according to risk status: Secondary prevention of small subcortical strokes trial. J Stroke Cerebrovasc Dis 2014; 23(4): 618-24.
[29]
Toni D, Di Angelantonio E, Di Mascio MT, Vinisko R, Bath PM, Group PRS. PRoFESS Study Group. Types of stroke recurrence in patients with ischemic stroke: A substudy from the PRoFESS trial. Int J Stroke 2014; 9(7): 873-8.
[30]
Wang Y, Xu J, Zhao X, et al. Association of hypertension with stroke recurrence depends on ischemic stroke subtype. Stroke 2013; 44(5): 1232-7.
[31]
Moroney JT, Bagiella E, Paik MC, Sacco RL, Desmond DW. Risk factors for early recurrence after ischemic stroke: The role of stroke syndrome and subtype. Stroke 1998; 29(10): 2118-24.
[32]
Amarenco P, Lavallée PC, Labreuche J, et al. TIAregistry.org Investigators. One-year risk of stroke after transient ischemic attack or minor stroke. N Engl J Med 2016; 374(16): 1533-42.
[33]
Lee M, Saver JL, Hong KS, Rao NM, Wu YL, Ovbiagele B. Antiplatelet Regimen for patients with breakthrough strokes while on Aspirin: A systematic review and meta-analysis. Stroke 2017; 48(9): 2610-3.
[34]
Eikelboom JW, Connolly SJ, Bosch J, et al. COMPASS Investigators. Rivaroxaban with or without Aspirin in stable cardiovascular disease. N Engl J Med 2017; 377(14): 1319-30.
54
2